Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Eli Lilly
LLY
|
$788M |
| 2 |
Uber
UBER
|
$600M |
| 3 |
Netflix
NFLX
|
$441M |
| 4 |
Goldman Sachs
GS
|
$414M |
| 5 |
Microsoft
MSFT
|
$412M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$786M |
| 2 |
Nike
NKE
|
$750M |
| 3 |
Walt Disney
DIS
|
$743M |
| 4 |
Edwards Lifesciences
EW
|
$702M |
| 5 |
Illumina
ILMN
|
$618M |
Sector Composition
| 1 | Technology | 30.69% |
| 2 | Consumer Discretionary | 19.06% |
| 3 | Healthcare | 13.05% |
| 4 | Communication Services | 12.23% |
| 5 | Financials | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
NovoCure
NVCR
$1.44B
| $889K | ﹤0.01% |
13,201
-179
| -1% | -$12.1K |
|
502
Wabash National
WNC
$470M
| $866K | ﹤0.01% |
119,992
+82,230
| +218% | +$593K |
|
503
Progressive
PGR
$143B
| $849K | ﹤0.01% |
+11,493
| New | +$849K |
|
504
First Industrial Realty Trust
FR
$6.86B
| $845K | ﹤0.01% |
+25,440
| New | +$845K |
|
|
PRFT
505
DELISTED
Perficient Inc
PRFT
| $842K | ﹤0.01% |
+31,097
| New | +$842K |
|
506
Eventbrite
EB
$251M
| $840K | ﹤0.01% |
115,023
-88,077
| -43% | -$643K |
|
507
NeoGenomics
NEO
$1.01B
| $838K | ﹤0.01% |
+30,347
| New | +$838K |
|
508
Taylor Morrison
TMHC
$7.01B
| $837K | ﹤0.01% |
76,048
+37,257
| +96% | +$410K |
|
509
AMN Healthcare
AMN
$773M
| $771K | ﹤0.01% |
+13,343
| New | +$771K |
|
510
Federated Hermes
FHI
$4.07B
| $768K | ﹤0.01% |
40,341
+6,988
| +21% | +$133K |
|
|
LTC
511
LTC Properties
LTC
$1.68B
| $767K | ﹤0.01% |
24,826
+142
| +0.6% | +$4.39K |
|
512
Hilltop Holdings
HTH
$2.19B
| $759K | ﹤0.01% |
50,194
+1,626
| +3% | +$24.6K |
|
|
VRE
513
Veris Residential
VRE
$1.51B
| $737K | ﹤0.01% |
48,423
+21,209
| +78% | +$323K |
|
514
Medpace
MEDP
$13.6B
| $728K | ﹤0.01% |
9,916
+235
| +2% | +$17.3K |
|
|
NS
515
DELISTED
NuStar Energy L.P.
NS
| $723K | ﹤0.01% |
+84,197
| New | +$723K |
|
|
MODN
516
DELISTED
MODEL N, INC.
MODN
| $721K | ﹤0.01% |
+32,443
| New | +$721K |
|
517
Itron
ITRI
$5.51B
| $718K | ﹤0.01% |
+12,868
| New | +$718K |
|
|
TECD
518
DELISTED
Tech Data Corp
TECD
| $706K | ﹤0.01% |
5,396
+949
| +21% | +$124K |
|
519
UFP Industries
UFPI
$5.98B
| $684K | ﹤0.01% |
18,402
-10,716
| -37% | -$398K |
|
520
Kennedy-Wilson Holdings
KW
$1.19B
| $672K | ﹤0.01% |
50,058
+9,016
| +22% | +$121K |
|
521
Bio-Rad Laboratories Class A
BIO
$7.8B
| $671K | ﹤0.01% |
+1,915
| New | +$671K |
|
522
CBIZ
CBZ
$3.11B
| $670K | ﹤0.01% |
32,007
+352
| +1% | +$7.37K |
|
523
Portland General Electric
POR
$4.63B
| $654K | ﹤0.01% |
13,645
-283
| -2% | -$13.6K |
|
524
KB Home
KBH
$4.56B
| $641K | ﹤0.01% |
+35,424
| New | +$641K |
|
525
HUB Group
HUBG
$2.26B
| $633K | ﹤0.01% |
+27,860
| New | +$633K |
|